# Integrated Dual Exercise and Lexiscan Positron Emission Tomography: IDEALPET

> **NCT01109992** · PHASE4 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 43 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Exercise plus Regadenoson (Lexercise)
- **DRUG:** Regadenoson (Lexiscan)

## Key facts

- **NCT ID:** NCT01109992
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2017-06-06
- **Final completion:** 2017-06-06
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2018-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01109992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01109992, "Integrated Dual Exercise and Lexiscan Positron Emission Tomography: IDEALPET". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01109992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*